1217 Aurora Peptomyc
BioCentury & Getty Images


New Italian VC’s first play is Spanish biotech chasing notoriously difficult target 

AurorA leads series A for Peptomyc

AurorA Science’s first investment is in Barcelona-based Peptomyc, which is pursuing therapies against one of life sciences’ most infamous oncogene targets.

Read the full 463 word article

How to gain access

Continue reading with a
two-week free trial.